Condition: Nutrition Intake · Nutrition Status · Gastrointestinal Microbiome · Sponsor: Athletic Greens International
This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.
This description comes directly from the study's public registry record.
Ellen O'Gorman · (805) 292-0714 · ellen@citruslabs.com
Jodi Nicolli · jodi@citruslabs.com
Always discuss trial participation with your own doctor first.
| Citruslabs | Santa Monica, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07437911